Vaccines for Biodefense and Emerging and Neglected DiseasesThe last 20 years has seen a rapid increase in infectious diseases, particularly those that are termed "emerging diseases" such as SARS, "neglected diseases" such as malaria and those that are deemed biothreats such as anthrax. It is well-recognized that the most effective modality for preventing infectious diseases is vaccination. This book provides researchers with a better understanding of what is currently known about these diseases, including whether there is a vaccine available or under development. It also informs readers of the key issues in development of a vaccine for each disease.
|
Other editions - View all
Vaccines for Biodefense and Emerging and Neglected Diseases Alan D. T. Barrett,Lawrence R. Stanberry No preview available - 2009 |
Common terms and phrases
adenovirus adjuvant agents alphavirus animal models anthrax antibody responses antigen avian avian influenza bacterial Biodefense biological capsid cause CD8 T cells cells cellular Center challenge Clin clinical trials cytokines dengue virus DNA vaccine dose Drug Ebola effective efficacy encephalitis virus encoding epidemic epitopes evaluation expression FMDV Gardasil gene genetic genome glycoprotein Guidance for Industry hantavirus Health hemorrhagic fever hepatitis C virus HFRS host human papillomavirus immu immune responses immunodeficiency virus immunogenicity Immunol inactivated induce infectious diseases influenza vaccine influenza virus laboratory live attenuated mice neutralizing antibody outbreaks pandemic particles pathogenesis pathogens patients phase plasmid potential prevent protective immunity protein recombinant replication reported respiratory risk Schmaljohn serotypes strains studies syndrome T-cell testing tion titers vaccine candidates vaccine development vaccinia VEEV viral viremia Virol Virology virus infection virus type virus vaccine viruses WEEV